InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
InMode Ltd. (INMD) launched Morpheus8 Cool, an advanced RF microneedling technology with enhanced comfort and control. The new handpiece features Cool Comfort Technology and an interactive user interface. The company reports high demand and positive feedback from providers.
How this was made
The 30-second read
Why it matters
The launch introduces a cooling feature aimed at improving patient comfort, potentially expanding the addressable market.
Market read
A product launch that could modestly boost InMode's sales pipeline but lacks immediate quantitative impact.
What to watch
Pricing, reimbursement, and adoption speed are unknown and could dampen the expected benefit.
Background
InMode is a Nasdaq‑listed developer of RF‑based medical aesthetic devices.
Ticker impact
InMode announced the launch of Morpheus8 Cool, a new RF microneedling handpiece on its Morpheus8MAX platform.
Potential modest upside as clinics adopt the new handpiece; upside limited without pricing details.
Launches of incremental device upgrades typically generate short‑term interest but limited immediate revenue impact.
Market effects
May reinforce InMode's position in the aesthetic medical device sector and could prompt competitor responses.
Primarily U.S. aesthetic clinics; limited broader regional effect.
Limited to markets where InMode sells devices; no immediate macro impact.
Counterpoint
The upgrade may be seen as a minor tweak that will not materially shift market share or earnings.
Key entities
- CompanyInMode Ltd.
Manufacturer of the Morpheus8 platform.
- ProductMorpheus8 Cool
New RF microneedling handpiece with cooling technology.
